Clinical Research From Commitment to Action Lisboa November 9, 2016
|
|
- Marshall Austin
- 5 years ago
- Views:
Transcription
1 Clinical Research From Commitment to Action Lisboa November 9, 2016 Jeffrey Yachnin MD, PhD Clinical Trials Unit Department of Oncology Karolinska University Hospital Namn Efternamn November 16,
2 sailors with scurvy: 6 treatments 1.1 l cider 25 ml Vitriol (diluted sulphuric acid) 18 mls vinegar (3 times daily) Half liter of seawater Paste mustard seeds, garlic, dried radish root... 2 oranges and 1 lemon for 6 days Namn Efternamn November 16,
3 Number of Drugs in Development Berggren et al Nature Rev Drug Discovery 2012 Namn Efternamn November 16,
4 20 Year Anniversary Clinical Trials Unit Department of Oncology 456 studies 17,000 screened 6,700 patients included Namn Efternamn November 16,
5 Studies Open For Inclusion Studies in Follow-Up Academic Sponsor Patient Inclusion New Studies % As of Oct 1, 2016
6 Clinical Trials Unit Department of Oncology Early Clinical Trials Unit Phase II IV Unit Tissue and blood coordinators Clinical Trials Office Namn Efternamn November 16,
7 Clinical Trials Unit Department of Oncology 1 physician 1 head nurse 17 research nurses 6 employees Clinical Trials Office 2 blood and tissue sample coordinators 1 economist Namn Efternamn November 16,
8 Clinical Trials Unit Department of Oncology Salaries Rent Computers Telephones Cleaning 10% overhead to the hospital Namn Efternamn November 16,
9 Clinical Trials Office Coordination of Studies Applications Database creation and management ecrf Randomization Safety reporting Monitoring Namn Efternamn November 16,
10 Clinical Trials Office Namn Efternamn November 16,
11 Clinical Trials Office Namn Efternamn November 16,
12 Clinical Trials Office Namn Efternamn November 16,
13 Priority Council Section Head Clinical Trials Unit (Chairman) Head Research Nurse Clinical Trials Unit Section Heads from the diagnosis groups Nursing Representative Chairman of the Department of Oncology Representative from Karolinska Institute Representative from Radiation Oncology Namn Efternamn November 16,
14 Priority Council Meeting every 2 weeks Up to 4 studies/meeting 15 minutes/study PI or co-investigator present the proposal Namn Efternamn November 16,
15 Priority Council Scientific value? Resources? Ethics? Competing studies? Study Design? Sub-studies? Namn Efternamn November 16,
16 Value of Clinical Research From which perspective? Patients (now and in the future) Doctors/Nurses/Scientists Health Authorities Pharmaceutical/Medical Technology industries Namn Efternamn November 16,
17 Value of Clinical Research... all clinical trials, including those with academic sponsors, must be fully financed Simple economics... you can`t get a dividend if you don`t make an investment Scot Trial in Colorectal Cancer SOLD Breast Cancer Trial Namn Efternamn November 16,
18 Value of Clinical Research Drug costs for oncology at Karolinska approx. 30 million EUR/year Estimated annual savings from drug costs from clinical trials 2.5 million EUR Namn Efternamn November 16,
19 Three Critical Elements in Implementation Establish geographic infrastructure (physically close) Integration of clinical research Guidelines and standards that apply to all studies Remember its the people not the organisation that are critical Start training younger colleagues distribute PI responsibilities Clinical PIs!!!! Take into account changing social structure Cross-Country Referral Solve problems at grassroots, not political solutions Namn Efternamn November 16,
20 Key Annual Performance Indicators For Clinical Research Number of patients included in clinical trials (10% increase) Number of new clinical trials opened Percentage of academic sponsors Amount of external funding Namn Efternamn November 16,
21 Namn Efternamn November 16,
22 Getting Started With Academic Studies Resource Distribution Big Pharma manufacturing R & D marketing Namn Efternamn November 16,
23 Thank-you Namn Efternamn November 16,
August 17, The Testimony of Christopher P. Molineaux President & CEO Pennsylvania Bio
Joint Democratic and Republican House Policy Committee Hearing August 17, 2016 The Testimony of Christopher P. Molineaux President & CEO Pennsylvania Bio Chairman Benninghoff, Chairman Sturla, and members
More informationBoundaryless Hospital - Rethink and Redefine Health Care Management. New Chains of Value Creation
Boundaryless Hospital - Rethink and Redefine Health Care Management New Chains of Value Creation Sören T. Eichhorst, MD PhD Partner and Head of McKinsey Hospital Institute Cologne, Germany PROPRIETARY
More informationMake an Executive Decision to Fight Cancer.
Make an Executive Decision to Fight Cancer. A Message from President and CEO, Edward J. Benz, Jr., MD President s circle Corporate Leaders Few institutions can match the strength and leadership that Dana-Farber
More informationAndalusian Agency for Health Technology Assessment (AETSA)
Andalusian Agency for Health Technology Assessment (AETSA) Seville, 22 nd of July, 2016 Comments on the concept paper Facilitating the translation of advanced therapies to patients in Europe 1 Introduction
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationWael Al-Delaimy MD, PhD. President, Society for Advancement of Science and Technology in the Arab World
Wael Al-Delaimy MD, PhD President, Society for Advancement of Science and Technology in the Arab World Professor and Chief, Division of Global Health University of California, San Diego First Science Institute:
More informationT h a n k y o u f o r y o u r s u p p o r t
2 0 1 0 working with Christmas Charity Card C ollection 10p per card to Cancer Research UK T h a n k y o u f o r y o u r s u p p o r t B u s i n e s s a n d p e r s o n a l i s e d C h r i s t m a s C
More informationHealth Technology Assessment (HTA) Dr Hamid Ravaghi
Health Technology Assessment (HTA) Dr Hamid Ravaghi Why? What? How? 3 Why? New technologies Cost of new technologies Limited resources Ethical questions WHAT? Health Technology Instruments, equipment,
More informationThe Leeds Teaching Hospitals NHS Trust. Beads of Courage. Information for patients. org
n The Leeds Teaching Hospitals NHS Trust Beads of Courage Information for patients org The Beads of Courage Programme is a new concept being introduced in the UK which is designed to support children and
More informationHealth Innovations in Horizon 2020: the framework programme for research and innovation ( )
Health Innovations in Horizon 2020: the framework programme for research and innovation (2014-2020) Virginija Dambrauskaite, MD, PhD Scientific Officer, Medical Research Unit, Health Directorate Directorate-General
More informationDriving profitable growth in Greater China. Andy Ho Chief Market Leader Greater China
Driving profitable growth in Greater China Andy Ho Chief Market Leader Greater China Key takeaways China HealthTech market is the 2 nd largest globally and exhibits continued robust growth with significant
More informationDiscovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More informationCarolinas HealthCare Foundation. Annual Report 2016
Carolinas HealthCare Foundation Annual Report 2016 Today, multiple programs and services throughout Carolinas HealthCare System are being supported or significantly enhanced by philanthropy. Children s
More informationSecurity and Risk Assessment in GDPR: from policy to implementation
Global Data Privacy Security and Risk Assessment in GDPR: from policy to implementation Enisa Workshop Roma - February 8, 2018 Nicola Orlandi Head of Data Privacy Pharma Nicola Orlandi Nicola Orlandi is
More informationStrategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use
Strategies for Knowledge Translation and Mobilization to Inform Hospital Health Technology Use Rosmin Esmail MSc, CHE Director, Knowledge Translation Research, Analytics and Innovation Portfolio Alberta
More informationIMI Revolutionising Europe s Pharmaceutical Industry. IMI Matters!
IMI Revolutionising Europe s Pharmaceutical Industry IMI Matters! Session in the Framework of the Event Joint Technology Initiatives Innovation in Action 4 6 October 2011 European Parliament Brussels Programme
More informationResearch Development Request - Profile Template. European Commission
Research Development Request - Profile Template European Commission Research Development Request Profile The following table can be used as a template for drafting a Research Development Request profile.
More informationThe Board of Directors of University Hospital. PUBLIC SESSION January 24, :30 a.m.
The Board of Directors of University Hospital PUBLIC SESSION January 24, 2017 8:30 a.m. Rutgers New Jersey Medical School/University Hospital Cancer Center 205 South Orange Avenue, Board Room B-1120 Newark,
More informationDraft Plan of Action Chair's Text Status 3 May 2008
Draft Plan of Action Chair's Text Status 3 May 2008 Explanation by the Chair of the Drafting Group on the Plan of Action of the 'Stakeholder' Column in the attached table Discussed Text - White background
More informationThe Danish-American Entrepreneurship Summit
The Danish-American Entrepreneurship Summit Insights Into the US Venture Capital Markets How to Create A Winning Strategy? Clare Fairfield Do Innovation Development Systems Matter? In 2003, venture backed
More informationCentre for the Advancement of Health Innovations (CAHI)
Centre for the Advancement of Health Innovations (CAHI) Excellence in Clinical Innovation and Technology Evaluation Monday, April 16 th, 2012 The Old Mill Inn and Spa, Toronto ON Leslie Levin MB, MD, FRCP
More informationUsing information to develop a research strategy: challenges and opportunities
0 Using information to develop a research strategy: challenges and opportunities Scott Rutherford Director of Research and Enterprise Queen s University Belfast October 11, 2017 1 Timeline for this presentation
More information7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August Exhibitor Prospectus. About the Course
7th Annual Oncology Update A CME review of the 2010 ASCO Annual Meeting June August 2010 Exhibitor Prospectus About the Course During Scripps Clinic s Oncology Update course, clinical experts will review
More informationEU s Innovative Medical Technology and EMA s Measures
EU s Innovative Medical Technology and EMA s Measures 27 October 2017 Summit symposium 25-27 October 2017, Kyoto, Japan Presented by Guido Rasi Executive Director, European Medicines Agency (EMA) An agency
More informationThe EFPIA Perspective on the GDPR. Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference , Helsinki
The EFPIA Perspective on the GDPR Brendan Barnes, EFPIA 2 nd Nordic Real World Data Conference 26-27.9.2017, Helsinki 1 Key Benefits of Health Data Improved decision-making Patient self-management CPD
More informationINVESTOR PRESENTATION!
INVESTOR PRESENTATION ENHANCING HEALTH THROUGH CANNABIS SCIENCE WWW.EMERALDHEALTH.CA TSX.V:EMH TSX.V:EMH Disclaimer THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE FORWARD-LOOKING STATEMENTS REGARDING
More informationTranslational scientist competency profile
C-COMEND Competency profile for Translational Scientists C-COMEND is a two-year European training project supported by the Erasmus plus programme, which started on November 1st 2015. The overall objective
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationEU Research Integrity Initiative
EU Research Integrity Initiative PROMOTING RESEARCH INTEGRITY IS A WIN-WIN POLICY Adherence to the highest level of integrity is in the interest of all the key actors of the research and innovation system:
More informationThe Friends and Family Test score is calculated as outlined in the NHS England guidance issued in Oct-14. The calculation is as follows:
10 Children s outpatients department - NDDH - Friends and Family Test - Jun-15 to Jul-15 Friends and Family Test question: If your friends and family needed similar care or treatment to you, do you think
More informationheadspace Bairnsdale Private Practitioners: Model for Operations and Support
1 headspace Bairnsdale Private Practitioners: Model for Operations and Support May 2017 2 Table of Contents Introduction to headspace Bairnsdale... 3 Operational Model:... 3 Operational model general practitioners...
More informationPowered by: Norway for Life Science. Photo cover: Christopher Olssøn Design: Fete typer
Powered by: Norway for Life Science Photo cover: Christopher Olssøn Design: Fete typer Content Photo: Istockphoto The Value of the Health Industry 4 The Research Council of Norway 6 Innovation Norway 8
More information(Fig.) JPMA Industry Vision 2025
2. JPMA Industry Vision 2025 Against the background of the changing environment surrounding the pharmaceutical industry and the future predictions *1, we prepared JPMA Industry Vision 2025 Bringing Innovation
More informationHealth Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities
Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities Aleksandra Torbica, Carlo Federici, Rosanna Tarricone Centre for Research on Health and
More informationKate Pretty Lecture Thursday 8 March Pascal Soriot, CEO AstraZeneca. What Science Can Do The Cambridge Cluster at a Pivot Point
Kate Pretty Lecture Thursday 8 March 2018 Pascal Soriot, CEO AstraZeneca What Science Can Do The Cambridge Cluster at a Pivot Point Introduction Thank you for your invitation and warm welcome to Homerton
More informationReview Questions on Ch4 and Ch5
Review Questions on Ch4 and Ch5 1. Find the mean of the distribution shown. x 1 2 P(x) 0.40 0.60 A) 1.60 B) 0.87 C) 1.33 D) 1.09 2. A married couple has three children, find the probability they are all
More informationCollaborating with the Office of Technology Transfer
Collaborating with the Office of Technology Transfer Todd Sherer, Ph.D. Associate Vice President for Research and Executive Director Office of Technology Transfer Emory Owns Our IP As a condition of employment,
More informationAnnual Press Conference Financial year 2017
Annual Press Conference 2018 Financial year 2017 Financial year Hubertus von Baumbach Chairman of the Board of Managing Directors 2017 Highly successful financial year 2017 Major success with human pharmaceuticals
More informationThe value of innovative pharmaceuticals and the potential for Vietnam. Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016
The value of innovative pharmaceuticals and the potential for Vietnam Mr. Koen Kruytbosch, Vice-Chairman of Pharma Group Vietnam 6 th October, 2016 PHARMA GROUP Our priority is to ensure that Vietnamese
More informationRoche in Mannheim. The high-tech campus
Roche in Mannheim The high-tech campus Welc to Roche in me Mannheim Our Site We make a difference along the entire Roche value chain. Our goal at Roche in Mannheim is to use our skills and knowledge to
More informationWelcome to Althea. Welcome to the future of integrated healthcare technology management
Welcome to Althea Welcome to the future of integrated healthcare technology management Modern healthcare systems face a huge challenge: how to offer better care to more people at affordable cost. Technology
More informationHigher Education Contribution to Health Science Innovation
Scottish University of the Year 2017 Higher Education Contribution to Health Science Innovation Professor Sir Pete Downes Principal, University of Dundee Lead Member for Health, Universities Scotland 28
More information4.1. Accurate: The information is a true reflection of the original observation.
SOP #: DOC-101 Page: 1 of 7 Effective Date: 1. POLICY STATEMENT: The Principal Investigator and research team members are required to prepare and maintain adequate and accurate case histories designed
More informationScottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund
Scottish Health and Life Sciences Innovation Workshop The Industrial Strategy Challenge Fund Ian Campbell Innovate UK, Director of Health &Life Sciences Email:Ian.Campbell@innovateuk.gov.uk Twitter: @IanWCampbell
More informationMaking lives better every day. This is UCB
Making lives better every day. This is UCB Kristof, living with axial spondyloarthritis Remi, UCB Inspired by patients. Driven by science. We have a shared ambition to transform the lives of people living
More informationWhen Must a Non-UH Investigator Seek Review by the UH IRB? the Issue of Engagement
University of Hawai i HRPP Standard Operating Procedures When Must a Non-UH Investigator Seek Review by the UH IRB? the Issue of Engagement Purpose and Scope SOP 103 Date: December 18, 2015 The question
More informationGood afternoon. Under the title of Trust and Co-creation in the Digital Era, I would like to explain our research and development strategy.
Good afternoon. Under the title of Trust and Co-creation in the Digital Era, I would like to explain our research and development strategy. LABORATORIES LTD. 1 Looking back, it has been 83 years since
More informationTwenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years
Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years Chris Evennett & Professor James Barlow The context Demographics On-going financial constraints
More informationSustainable Society Network+ Research Call
Sustainable Society Network+ Research Call Call for Pilot Studies and Challenge Fellowships Closing date: 17:00 on 31 st October2012 Summary Applicants are invited to apply for short- term pilot study
More informationKen Buetow, Ph.D. Director, Computation Science and Informatics, Complex Adaptive ASU Professor, School of Life Science
COMPLEX ADAPTIVE SYSTEMS Ken Buetow, Ph.D Director, Computation Science and Informatics, Complex Adaptive Systems @ ASU Professor, School of Life Science Kenneth.Buetow@ASU.edu 1 4 th Paradigm Science
More informationNEWS RELEASE. Life sciences companies tout their expertise in India
For Immediate Release 2014MIT0016-000196 Feb. 19, 2014 NEWS RELEASE International Trade and Responsible for the Asia Pacific Strategy and Multiculturalism Life sciences companies tout their expertise in
More informationWASHINGTON,D.C FORM8-K. CURRENTREPORT PursuanttoSection13or15(d)ofthe. Date of Report (Date of the earliest event reported): October29,2018
UNITEDSTATES SECURITIESANDEXCHANGECOMMISSION WASHINGTON,D.C.20549 FORM8-K CURRENTREPORT PursuanttoSection13or15(d)ofthe SecuritiesExchangeActof1934 Date of Report (Date of the earliest event reported):
More informationHuman Biological Material Collection, Storage and Use
Avenue E. Mounier 83/11 1200 Brussels Belgium Tel: +32 2 774 1611 Email: eortc@eortc.be www.eortc.org Human Biological Material Collection, Storage and Use POL020 Version 2.1 ALWAYS REFER TO THE INTERNET
More informationHow Machine Learning and AI Are Disrupting the Current Healthcare System. Session #30, March 6, 2018 Cris Ross, CIO Mayo Clinic, Jim Golden, PwC
How Machine Learning and AI Are Disrupting the Current Healthcare System Session #30, March 6, 2018 Cris Ross, CIO Mayo Clinic, Jim Golden, PwC 1 Conflicts of Interest: Christopher Ross, MBA Has no real
More informationAMCo current. Medpace new in Sebia realised. Spire Healthcare partially realised. Healthcare. Sector insights. Our Healthcare portfolio in 2014
Sector insights The healthcare market is highly complex with global products delivered through local services and channels. The healthcare value chain is intricate, diverse and interdependent. It is a
More informationCountry Report of the Philippines. By Dr. Estrella F. Alabastro Secretary Department of Science and Technology
Country Report of the Philippines By Dr. Estrella F. Alabastro Secretary Department of Science and Technology Excellencies Distinguished Delegates Ladies and Gentlemen: It is a great pleasure and an honor
More informationPRISME Technical Forum Introduction Accelerating Disruption
PRISME Technical Forum Introduction Accelerating Disruption Presenters: Matthew Rich and Jim Golden Agenda Following the Money: Venture Capital s Influence on Pharma Tech Applications and Possibilities
More informationHorizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission
Horizon 2020 Societal Challenge 1: Health, demographic change and wellbeing Jeremy Bray DG Research & Innovation European Commission National NHS day Leeds, UK, 29 January 2014 What is Horizon 2020? The
More informationResearch and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research
Page 1 of 9 Research and Innovation Strategy and Action Plan 2012 2015 UPDATE Advancing knowledge and transforming lives through education and research Executive Summary As the enterprise university, Plymouth
More informationWe Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations
We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have
More informationInvestor Presentation & Financial Highlights. November 2018
Investor Presentation & Financial Highlights November 2018 Forward Looking Statements Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties.
More informationThis is SINTEF May Technology for a better society
This is SINTEF 2011 May 2011 Our vision: Our role Creating value by applying knowledge, research and innovation Delivering solutions for sustainable development Building and operating research laboratories
More informationComprehensive Research Services
Comprehensive Research Services Scripps Health: At the Forefront of Clinical Research Scripps Health is a recognized leader in clinical research and has long been at the forefront of numerous medical breakthroughs.
More informationJustice Select Committee: Inquiry on EU Data Protection Framework Proposals
Justice Select Committee: Inquiry on EU Data Protection Framework Proposals Response by the Wellcome Trust KEY POINTS The Government must make the protection of research one of their priorities in negotiations
More informationGenerex Biotechnology Provides 2018 Year-End Summary & 2019 Plans
Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans - Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, January 22, 2019 - Generex Biotechnology Corporation (www.generex.com)
More informationEvaluation format: Qualitative, Quantitative, External involvement Evaluation measurement tools Pre and post evaluation Reporting and disseminating
Tips when working with organisations Practical & ethical considerations Is a quick fix needed? Is there adequate support and commitment? What are the logistics? (shift patterns, geographical spread of
More informationFinn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark
EUnetHTA European network for Health Technology Assessment DATABASES, REGISTRIES AND OTHER DATA CAPTURE TOOLS: HOW CAN WE AVOID MULTIPLICITY AND CREATE AN INTEGRATED DATA-CAPTURE APPROACH ALONG THE PRODUCT
More information202, million 2.1. Our scale, our diversification and the predictability of our business give us strong foundations on which to innovate
In 2017 we obtained excellent results the right way: through profitable growth Ana Botín, Group executive chairman of Banco Santander Our success in 2017 shows that our way of doing business, and our focus
More informationMax Planck Florida Institute for Neuroscience Update Board of County Commissioners October 29, 2013 Workshop
Max Planck Florida Institute for Neuroscience Update Board of County Commissioners October 29, 2013 Workshop David Fitzpatrick, Ph.D. Scientific Director & CEO Matthias Haury, Ph.D. Chief Operating Officer
More informationDigital Health. Jiban Khuntia, PhD. Assistant Professor Business School University of Colorado Denver
Digital Health Jiban Khuntia, PhD Assistant Professor Business School University of Colorado Denver Digital Digital usually refers to something using digits, particularly binary digits. Examples: Digital
More informationTechnology for a better society
Main strategy Technology for a better society I am proud of SINTEF's vision, which both inspires and commits us. Our future will be characterised by new possibilities that will be created via a high level
More informationSpeaking with One Voice Unifying Scripps Under a Master Brand Strategy
Forum for Healthcare Strategists Healthcare Marketing Summit April 30, 2014 Speaking with One Voice Unifying Scripps Under a Master Brand Strategy Lynne Field, Strategy Director, Monigle Associates, Inc.
More informationConsumer and Community Participation Policy
Consumer and Community Participation Policy Responsible Officer: Contact Officer: Manager, Policy and Client Services Dr Natalie Wray (08) 6389 7304; nwray@ichr.uwa.edu.au Superseded Documents: PHRN Consumer
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationAn Essential Health and Biomedical R&D Treaty
An Essential Health and Biomedical R&D Treaty Submission by Health Action International Global, Initiative for Health & Equity in Society, Knowledge Ecology International, Médecins Sans Frontières, Third
More informationPublication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter
Publication Date Reporter Pharma Boardroom 24/05/2018 Staff Reporter Pharma Boardroom An Exclusive Interview with Jonathan Hunt CEO, Syngene International, India. Jonathan Hunt, CEO of Syngene International,
More informationThe Annual Irish America HEALTHCARE & LIFE SCIENCES 50
IRISH AMERICA MAGAZINE invites you to an awards dinner for The Annual Irish America HEALTHCARE & LIFE SCIENCES 50 THE NEW YORK YACHT CLUB 37 West 44 th Street New York City FRIDAY, November 2 nd, 2018
More informationThe Role of Patients in Transitions of Care
Play an Active Role It is crucial that you play an active role in your own healthcare. During treatment, you may see more than one provider. You also may visit more than one care setting. In each case,
More informationScripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011
Scripps Florida Accelerating Discoveries, Saving Lives Presentation to the Urban Land Institute November 4, 2011 Alex Bruner Associate Vice President, Philanthropy 1921- Founding of the Scripps Metabolic
More informationSan Diego. March 2, American College of Surgeons Surgical Health Care Quality Forum. American College of Surgeons
American College of Surgeons Inspiring Quality: Highest Standards, Better Outcomes American College of Surgeons Surgical Health Care Quality Forum San Diego March 2, 2012 Scripps Memorial Hospital La Jolla
More informationImplantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast,
Transparency Market Research Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 2018 Buy Now Request Sample Published Date: Mar 2013 Single User
More informationInnovation in HTA: What is the additional value?
Innovation in HTA: What is the additional value? Stirling Bryan Centre for Clinical Epidemiology & Evaluation, Vancouver Coastal Health Research Institute School of Population & Public Health, UBC My co-authors
More informationComputers and Medicine
Illinois Institute of Technology Computers and Medicine Alexander M. Nicoara CS485: History of Computers Professor Charles Bauer April 10th, 2016 What is the background of the topic? Computers play an
More informationThe European Investment Fund & Technology Transfer. Future Internet Assembly, Dublin 8 May 2013 Dr. Piyush Unalkat
The European Investment Fund & Technology Transfer Future Internet Assembly, Dublin 8 May 2013 Dr. Piyush Unalkat 1 What is the EIF? We re the leading developer of risk financing for entrepreneurship and
More informationCommission on science and Technology for Development. Ninth Session Geneva, May2006
Commission on science and Technology for Development Ninth Session Geneva, 15-19 May2006 Policies and Strategies of the Slovak Republic in Science, Technology and Innovation by Mr. Stefan Moravek Head
More informationFrom registers to personal data
The Fair Data Economy Promise From registers to personal data 28 11 2018 Jaana Sinipuro @jsinipuro A gift to Finland The Finnish Parliament established Sitra as a gift celebrating the 50th anniversary
More informationAI use in European healthcare
Artificial Intelligence (AI) AI use in European healthcare www.himss.eu/analytics Results, May 2018 1 TABLE OF CONTENT Introduction & methodology page 3 Survey questions page 4 Results Key Findings page
More informationParkinson s World A transformational project by The Cure Parkinson s Trust
Parkinson s World A transformational project by The Cure Parkinson s Trust Executive Summary During my time working in the Parkinson s field, I have come to realise there is a patent lack of communication
More informationENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL ICT SAT - Policy Pack. Engineering and Physical Sciences Research Council
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL ICT SAT - Policy Pack Engineering and Physical Sciences Research Council EPSRC Strategic Goals Shaping Capability Shaping Capability! Shaping capability
More informationINVESTING IN AMERICAN UNIVERSITY OF BEIRUT AMERICAN UNIVERSITY OF BEIRUT
AMERICAN UNIVERSITY OF BEIRUT PO Box 11-0236 Riad El Solh 1107 2020 Beirut, Lebanon (+961) 1 340 176, ext. 2530 AMERICAN UNIVERSITY OF BEIRUT THE DEBS CENTER 3 Dag Hammarskjold Plaza, 8th floor New York,
More informationOverview of Report Findings
1 Overview of Report Findings 2015-04-10 Brad Fenwick DVM, PhD. Senior Vice President Global Strategic Alliances Elsevier Washington, D.C. B.Fenwick@Elsevier.com http://www.csg.org/programs/knowledgeeconomy/background.aspx
More informationHow the EUPATI web site can support your efforts
All Aboard to a Better Health Future How the EUPATI web site can support your efforts 14 December 2016 The Square, Brussels, Belgium John Lenehan, Hibernia College What tools are on the web site? Articles
More informationGlobal Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner
Global Source Ventures, LLC Introduction Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner Introduction to Global Source Ventures GSV provides seed capital to emerging companies with emphasis
More informationDecember Eucomed HTA Position Paper UK support from ABHI
December 2008 Eucomed HTA Position Paper UK support from ABHI The Eucomed position paper on Health Technology Assessment presents the views of the Medical Devices Industry of the challenges of performing
More informationFinancing Growth Ventures to Minimize Equity Dilution
Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth
More informationResponsible Investing and Canadian Churches KAIROS/SHARE WORKSHOP
Responsible Investing and Canadian Churches KAIROS/SHARE WORKSHOP Where do we come from? 1968 Uppsala 1975 Creation Netherlands More than 30 years of experience Mission Oikocredit, as a worldwide cooperative
More informationLearning Lessons Abroad on Funding Research and Innovation. 29 April 2016
Learning Lessons Abroad on Funding Research and Innovation 29 April 2016 In South Africa universities contribute 2.1% of gross domestic product more than textiles and forestry and they employ 300,000 people
More informationDigital Health AI in Life Sciences
Digital Health AI in Life Sciences Surging Digital Health AI Fundraising Drives Transformation in Life Sciences DECEMBER Digital Health AI Accelerates Innovation in Life Science Industry Artificial intelligence
More informationMedical Education Activities
Medical Education Activities Author: Marie-Claire PICKAERT EFPIA Deputy Director General BioMed Alliance Brussels, 9 November 2016 MCP 07-11--2016 Declaration of Interest Marie-Claire Pickaert is a full-time
More informationResearch Strategy of Tampere University Community
Research Strategy of Tampere University Community Tampere university community is made up of the research-intensive Tampere University and development-focused Tampere University of Applied Sciences. These
More information